Jobs
View more job listings or post a job
Charles River Laboratories Senior Sales Specialist
Charles River Laboratories Senior Sales Specialist
Charles River Laboratories Research Associate
Charles River Laboratories Research Associate
EAG Laboratories Senior Scientist, Metabolism    
Bolt Biotherapeutics  Scientist I-II
FLX Bio, Inc. Research Associate, DMPK
Simulations Plus, Inc. Scientist/Sr. Scientist
UC Davis   Liquid Chromatography/Mass Spectrometry and Confirmation Supervisor Laboratory Research Supervisor 2  
BioMarin Associate Director / Sr. Scientist for Clinical Pharmacology
Post a job

Workshop

Preclinical development & IND Filing: Nuts, Bolts and Best Practices


Speakers: Tracy Chen, Jim Zhang, Peter Staehr, Anne Bonneville, Xingrong Liu
Organizers: Tracy Chen, Shichang Miao
Date: 1/22/2018
Time: 8:30-17:00
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For major-sponsor rep (incl lunch): $0; For vendor-show rep: $35;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Catalent Pharma Solutions; Medpace
Vendor show vendors registered to date: (23)Absorption Systems; Alcami; Applied StemCell Inc.; BioDuro; BRI Biopharmaceutical Research Inc.; Celerion; ChemPartner; Cyprotex; Cytovier LLC; Intertek; JOINN Labs; MicroConstants; Pacific BioLabs; PHARMout Laboratories; Pion Inc.; QPS; Quotient Clinical Ltd; Sekisui XenoTech, LLC; SNBL USA; SOLVO Biotechnology; Spaulding Clinical Research; Worldwide Clinical Trials; WuXi AppTec
Registration: http://www.PBSS.org
Registration deadline:1/21/2018  (it will close sooner if the seating cap is reached)

About the Topic

Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often, there are cases where too many nice-to-have studies crowd in the package but critical studies/issues are not addressed, and this can lead to significant delays in clinical development.  Additionally, the regulatory environment is changing as rapidly as the industry. Therefore, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety, PK, CMC, and clinical plan is paramount. 

In this workshop, our speakers highly experienced with IND filings will discuss systemically the preclinical studies required for small molecule IND filings and the nuts, bolts, and best practices for putting together a high-quality IND package, as well as how to interact with various regulatory agencies.

The following topics will be covered:

- Overview of preclinical development and IND filing 
- Various preclinical studies required (Safety, DMPK & CMC)
- Clinical Development plans
- Interfacing with regulatory agencies including FDA

 

Workshop Agenda:

8:45-9:15   PBSS Welcome and Introduction (Tracy Chen)

9:15-10:30  1. Chemistry, Manufacturing, and Controls (Jim Zhang)

10:30-10:40  Major Sponsor’s Presentation (Medpace)

10:40-10:55  Break

10:55-12:25  2. NonClinical Pharmacology & Pharmacokinetics (Xingrong Liu)

12:25-1:25  Lunch

1:25-3:25  3. Toxicology in Drug Development (Anne Killam Bonneville)

3:25-3:45  Break

3:45-3:55  Major Sponsor’s Presentation (Catalent)

3:55-5:00  4. Clinical Development Plan and Interaction with FDA (Peter Staehr)

5:00-5:30  Panel Discussion (All Speakers)


2018-08-03, The New EMA Guideline and Evolving Expectations for Patient Safety in First-in-Human Clinical Trials: Keeping the Focus on the Science
2018-09-12, Antibody Drug Conjugates: Chemistry, Biology, Pharmacokinetics and Toxicology
2018-09-27, Small Molecule Formulation Development: Strategies for challenging APIs ((jointly with AAPS-BADG)
2018-10-16, Drug-Drug Interactions: Preclinical Risk Assessment and Review of the new FDA Guidance
2018-12-04, Challenges in Peptide Discovery & Drug Development: Biology, Chemistry, PK, Delivery, Regulatory and Beyond
©Pharmaceutical & BioScience Society, International; Last Modified: 6/20/2018; Visited: 555; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

Simulations Plus The new ADMET Predictor™ 8.5 - Powerful ADMET Property Estimation, at your fingertips! Request an evaluation today.
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact: kelvin.lam@reactionbiology.com
Simulations Plus GastroPlus™ developers launch PKPlus™. Generate validated PK reports for regulatory submissions. Value pricing/licensing. Request an evaluation today.
Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
Hypha Discovery Specialists in provision of drug metabolites at mg-g scale, including CYP/Non-CYP metabolites and conjugates such as glucuronides/sulfates.
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
Simulations Plus Are you ready to integrate in silico modeling & simulation to augment your research activities, but don’t have the time or resources? We can help!
Submit a Text Ad